Home Categories API Pentostatin
A6781912

Pentostatin , 98%(HPLC) , 53910-25-1

Synonym(s):
(8R)-3-(2-Deoxy-β-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol;2ʹ-Deoxycoformycin, (8R)-3-(2-deoxy-β-D-erythro- pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol, Pentostatin, S. antibioticus;2′-dCF;DCF;Deoxycoformycin

CAS NO.:53910-25-1

Empirical Formula: C11H16N4O4

Molecular Weight: 268.27

MDL number: MFCD00078802

Pack Size Price Stock Quantity
5MG RMB439.20 In Stock
25MG RMB2020.00 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: 154-157?C
alpha  D25 +76.4° (c = 1 in water); D23 +73.0° (c = 1, pH 7 buffer)
Boiling point: 411.43°C (rough estimate)
Density  1.2576 (rough estimate)
refractive index  1.6081 (estimate)
storage temp.  -20°C
solubility  H2O: soluble10mg/mL, clear
pka 5.2(at 25℃)
form  White solid
color  white to beige
optical activity [α]/D +70 to +80°, c = 1 in H2O

Description and Uses

Pentostatin, an adenosine deaminase inhibitor, is an orphan drug introduced for the treatment of hairy cell leukemia. The agent is considered a significant advance over alpha-interferon, the only other drug available for this indication. The majority of patients treated with pentostatin have been reported to remain in remission for at least four years. It is also under investigation for the treatment of other kinds of leukemia and in transplant rejection.

Pentostatin is a potent antitumor antibiotic isolated from a Streptomyces species. Pentostatin is a potent inhibitor of adenine deaminase and has been used therapeutically as an antitumor agent.

Safety

Symbol(GHS) 
GHS06
Signal word  Danger
Hazard statements  H301
Precautionary statements  P301+P310
Hazard Codes  Xn
Risk Statements  22
RIDADR  UN 2811 6.1 / PGIII
WGK Germany  3
HS Code  2933998090
Toxicity LD50 oral in mouse: 227mg/kg

RELATED PRODUCTS